Literature DB >> 16247094

What is the role of dipyridamole in long-term secondary prevention after an ischemic stroke or transient ischemic attack?

Cathie Sudlow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16247094      PMCID： PMC1266320          DOI： 10.1503/cmaj.050871

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Cardiac safety in the European Stroke Prevention Study 2 (ESPS2).

Authors:  H C Diener; H Darius; J M Bertrand-Hardy; M Humphreys
Journal:  Int J Clin Pract       Date:  2001-04       Impact factor: 2.503

2.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

3.  European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Authors:  H C Diener; L Cunha; C Forbes; J Sivenius; P Smets; A Lowenthal
Journal:  J Neurol Sci       Date:  1996-11       Impact factor: 3.181

Review 4.  Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.

Authors:  Jo Leonardi-Bee; Philip M W Bath; Marie-Germaine Bousser; Antoni Davalos; Hans-Christoph Diener; Bernard Guiraud-Chaumeil; Juhani Sivenius; Frank Yatsu; Michael E Dewey
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

5.  Dipyridamole in stroke prevention: effect of dipyridamole on blood pressure.

Authors:  E L L M De Schryver
Journal:  Stroke       Date:  2003-09-04       Impact factor: 7.914
  5 in total
  2 in total

Review 1.  Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA.

Authors:  Cathie Sudlow
Journal:  BMJ       Date:  2007-04-28

2.  Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.

Authors:  Te-I Chang; Cheng-Hsien Chen; Po-Hsun Huang; Chung-Te Liu; Hui-Ling Hsieh; Chun-You Chen; Shih-Chang Hsu; Ho-Shun Cheng; Wen-Cheng Huang; Yuh-Mou Sue; Yung-Ho Hsu; Feng-Yen Lin; Chun-Ming Shih; Shing-Jong Lin
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.